Equities

Adagio Medical Holdings Inc

ADGM:NAQ

Adagio Medical Holdings Inc

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (USD)2.80
  • Today's Change-0.075 / -2.61%
  • Shares traded2.99k
  • 1 Year change-74.19%
  • Beta-0.0780
Data delayed at least 15 minutes, as of Oct 18 2024 20:14 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Adagio Medical Holdings, Inc. is a medical device company developing and placing on the European Union (EU) market ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio consists of three product families: iCLAS atrial ULTC catheter and accessories, vCLAS ventricular ULTC catheter, and Cryopulse atrial PFCA catheter and accessories. All of these catheters share the same ULTC cryoablation console. A standalone PFA console connected to a cryoablation console for PFCA treatment synchronization is used in conjunction with Cryopulse catheter. The iCLAS system is CE-marked with the indication for treatment of paroxysmal atrial fibrillation, persistent atrial fibrillation and atrial flutter. The vCLAS ventricular catheter has been specifically designed for treatment of the ventricular arrhythmia. Its product offerings consist largely of the single use ablation catheters and consoles.

  • Revenue in USD (TTM)0.00
  • Net income in USD-2.54m
  • Incorporated2023
  • Employees--
  • Location
    Adagio Medical Holdings Inc26051 Merit Circle, Suite 102LAGUNA HILLS 92653United StatesUSA
  • Phone+1 (212) 284-2300
  • Fax+1 (302) 636-5454
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ADGM:NAQ since
announced
Transaction
value
Adagio Medical IncDeal completed14 Feb 202414 Feb 2024Deal completed-74.87%24.00m
Data delayed at least 15 minutes, as of Oct 18 2024 20:14 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Femasys Inc950.09k-16.69m28.90m32.00--2.57--30.42-0.8468-0.84680.04720.50600.05490.34387.6529,690.31-96.51---108.58--65.67---1,756.83--5.93-77.250.2972---11.13---25.04------
Vaso Corp80.33m2.26m28.94m300.0010.691.089.230.36020.01540.01540.45710.15241.1022.599.62267,766.703.107.605.0416.6261.2058.392.815.821.48--0.0028--2.181.84-57.46---22.33--
Neuronetics Inc72.07m-32.47m29.42m203.00--1.51--0.4083-1.10-1.102.450.64330.73092.314.76355,000.00-32.93-28.02-42.47-34.7375.9175.73-45.06-51.042.37-3.920.755--9.426.2218.76--18.57--
Meihua International Medical Tech Co Ltd94.25m9.28m29.63m617.003.050.18323.050.31430.34420.34423.455.730.551646.021.16152,759.405.4212.266.4315.0533.1238.149.8415.474.74--0.07290.00-6.055.1086.22-5.56-9.16--
Outset Medical Inc116.43m-159.18m30.32m480.00--0.4419--0.2604-3.14-3.142.291.320.35881.583.28242,552.10-49.06-41.40-57.18-47.2928.235.71-136.72-159.055.38-18.390.7417--13.00130.43-6.04--14.27--
DarioHealth Corp19.15m-46.52m30.93m223.00--0.4544--1.62-1.51-1.510.58032.270.162.393.3169,373.19-42.46-73.26-47.52-87.5930.9729.54-265.33-293.541.96--0.2961---26.4122.450.5091--52.42--
Movano Inc852.00k-26.83m33.42m30.00--1.99--39.23-0.4527-0.45270.01310.16960.0444--3.3828,400.00-139.74-151.50-176.37-188.58-87.21---3,149.06--5.23--0.0025------3.45--4.24--
Adagio Medical Holdings Inc0.00-2.54m37.49m----0.9379-----0.1856-0.18560.002.990.00-------6.73---9.12--------------0.1226-------299.85------
Singular Genomics Systems Inc2.72m-91.89m37.93m255.00--0.275--13.94-37.37-37.371.1155.270.01080.286711.5310,674.51-36.46---38.85---41.11---3,375.72--8.04--0.0696--280.52---4.34------
Rapid Micro Biosystems Inc24.71m-50.46m38.02m193.00--0.4019--1.54-1.17-1.170.57112.200.17781.335.58128,036.30-36.30---40.86---14.22---204.22--4.62--0.003--31.44--13.71------
IR-Med Inc0.00-3.47m38.91m6.00--107.12-----0.0499-0.04990.000.00510.00----0.00-197.95---273.36--------------0.3019-------3.70------
Co-Diagnostics Inc9.14m-37.57m40.85m155.00--0.5642--4.47-1.27-1.270.30772.270.09441.1911.0858,948.20-38.835.77-41.046.1559.8382.24-411.1910.948.81--0.000.00-80.09179.54-148.15--101.27--
Apyx Medical Corp49.03m-28.37m41.00m252.00--2.78--0.8363-0.8188-0.81881.420.42570.76721.823.96194,567.50-44.55-25.24-58.21-29.9761.9066.11-58.08-46.004.45-7.790.693--17.6125.8219.28--7.99--
Accelerate Diagnostics Inc12.23m-37.91m42.86m134.00------3.50-2.07-2.070.6853-1.470.33632.145.2891,291.05-104.22-75.24-1,349.93-94.4627.1635.08-309.87-638.551.04--6.38---5.4316.291.40--0.7307--
Lucid Diagnostics Inc3.80m-54.15m45.22m70.00------11.90-1.23-1.230.08570.32380.0992--38.9754,285.71-121.82---274.96---67.39---1,227.76--1.71--0.4178--544.03--6.24------
Vicarious Surgical Inc0.00-61.02m45.65m131.00--0.6334-----10.77-10.770.0012.220.00----0.00-61.68---66.62--------------0.00-------1,478.15------
Data as of Oct 18 2024. Currency figures normalised to Adagio Medical Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

75.94%Per cent of shares held by top holders
HolderShares% Held
Perceptive Advisors LLCas of 31 Jul 20247.16m53.49%
RA Capital Management LPas of 31 Jul 20241.34m9.99%
W.R. Berkley Corp. (Investment Portfolio)as of 30 Jun 2024319.46k2.39%
Glazer Capital LLCas of 30 Jun 2024235.08k1.76%
Fir Tree Capital Management LPas of 30 Jun 2024230.64k1.72%
Mizuho Securities USA LLCas of 30 Jun 2024208.79k1.56%
Farallon Capital Management LLCas of 30 Jun 2024200.00k1.49%
TD Securities (USA) LLCas of 30 Jun 2024174.28k1.30%
Tenor Capital Management Co. LPas of 30 Jun 2024150.00k1.12%
HSBC Bank Plc (Broker)as of 30 Jun 2024149.91k1.12%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.